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Results: Overall there were 126 patients with CRKB BSIs in the study period.
According to the latest minimum inhibitory concentration (MIC) interpretive
breakpoints for Enterobacteriaceae issued by the Clinical and Laboratory
Standards Institute (CLSI), 64 (50.8%) CRKP isolates were susceptible to cefe-
pime (total 126 isolates showed MIC range: 0.5-128; MIC90: 64 mg/L). Of 22
(17.5%) patients with cefepime-susceptible CRKP BSI, cefepime definitive
therapy showed a significantly lower mortality than other antibiotics (2/
22, 9.1% vs. 40/104, 38.5%, P Z 0.007). In logistic regression analysis, 30-
day mortality was independently associated with critical illness (odds ratio
[OR]: 14.6; 95% confidence interval [CI]: 4.2-50.9; P < 0.001); pneumonia
(OR: 7.3; 95% CI: 1.8-30.4; P Z 0.006); a rapidly fatal underlying disease
(OR 9.5; 95% CI 1.5-58.9; P Z 0.015), and definitive cefepime therapy
(OR: 0.1; 95% CI: 0.01-0.8; P Z 0.028).
Conclusions: Cefepime may be useful for the treatment of BSIs due to car-
bapenem-resistant but cefepime-susceptible K. pneumoniae, particularly if
source control is achieved.
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CARBAPENEM-RESISTANT VERSUS CARBAPENEM-SUSCEPTIBLE
ACINETOBACTER BAUMANNII BACTEREMIA IN A TEACHING HOSPITAL IN
CHINA: RISK FACTORS AND OUTCOMES
Fu Qiao, Wenzhi Huang. Infection Control Department, West China Hospital,
S.C.U., Chengdu, China
Purpose: The objective of this study was to compare the mortality associ-
ated with Carbapenem- resistant Acinetobacter baumannii (CRAB) versus
Carbapenem-susceptible Acinetobacter baumannii (CSAB) bacteremia, and
to determine specific risk factors for CRAB isolates in a 4300-bed teaching
hospital in China.
Methods: We performed a retrospective case-control study between January
1, 2010 and December 30, 2013. One hundred and sixty three patients with
CRAB bacteremia cases were compared to sixty eight unmatched patients
with CSAB bacteremia controls during the study period.
Results: The mortality rate was 32.5% and 4.4% in CRAB and CSAB cases
respectively (PZ 0.000). The risk factors for mortality were got bacteremia
with CRAB (hazard ratio [HR], 15.55; 95% confidence interval [CI], 3.27-
74.08; P Z 0.001), hematologic malignancy (HR, 13.77; 95%CI, 4.49-42.19;
P Z 0.000), cardiovascular disease (HR, 4.53; 95%CI, 1.34-15.26; P Z
0.015) and increasing of age (HR, 1.03; 95%CI, 1.01-1.05; P Z 0.000). By
multivariate analysis, the independent risk factors for CRAB bacteremia
compared to CSAB bacteremia were emergency visit (odds ratio [OR],
2.58; 95% CI, 1.10-6.06; P Z 0.029) and ICU stay (OR, 6.64; 95%CI, 2.26-
19.54; P Z 0.001) before infection.
Conclusions: The mortality rate was much higher among patients with CRAB
bacteremia. Led to emergency and stay in ICU were found to be independent
risk factors for bacteremia with CRAB.
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EFFICACY OF APPROPRIATE ANTIMICROBIAL THERAPY ON THE SURVIVAL
OF PATIENTS WITH CARBAPENEM NON-SUSCEPTIBLE KLEBSIELLA
PNEUMONIAE INFECTION: A MULTICENTER STUDY IN TAIWAN
Yi-Tsung Lin 1,2, Chien Chuang 1, Chin-Fang Su 1, Yin-Ching Chuang 3, L.
Kristopher Siu 4, Chang-Phone Fung 1,2. 1Division of Infectious Diseases,
Department of Medicine, Taipei Veterans General Hospital, Taiwan,
Taiwan; 2School of Medicine, National Yang-Ming University, Taipei, Taiwan;
3Department of Internal Medicine and Medical Research, Chi Mei Medical
Center, Tainan, Taiwan; 4Institute of Infectious Diseases and Vaccinology,
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Purpose: The impact of antimicrobial treatment on the outcome of carbape-
nem non-susceptible K. pneumoniae (CnsKP) infections needs to be eluci-
dated. This nationwide, multicenter study was conducted to evaluate the
impact of appropriate antimicrobial therapy on 14-day mortality among pa-
tients with CnsKP infection in Taiwan. Particular attention was focused on
the outcome related to different levels of disease severity.
Methods: Patients with CnsKP infections from 11 medical centers and four
regional hospitals in Taiwan were enrolled in 2013. Carbapenem non-suscep-
tibility was defined as a minimum inhibitory concentration of 2 mg/L for
imipenem or meropenem. Predictors of 14-day mortality were determined
using the Cox proportional regression model. The influence of infection
severity on the impact of appropriate use of antimicrobials on 14-day mor-
tality was determined using the Acute Physiology and Chronic Health Evalu-
ation (APACHE) II score.
Results: Overall 14-day mortality was 31.8% (49/154 patients). Unadjusted
mortality for appropriate antimicrobial therapy was 23.1% (18/78 patients).
Appropriate therapy was independently associated with reduced mortality
(hazard ratio [HR], 0.44; 95% confidence interval [CI], 0.24 to 0.80; P Z
0.007). A subgroup analysis revealed that the benefit of appropriate therapy
was limited to patients with higher APACHE II scores (HR for patients with
scores >15 and 35, 0.46 [95% CI, 0.23 e 0.92]; HR for those with scores
>35, 0.14; 95% CI, 0.02 e 0.99).
Conclusions: In conclusion, appropriate antimicrobial therapy significantly
reduces 14-day mortality for CnsKP infections. Survival benefit is more
notable among more severely ill patients.
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EPIDEMIOLOGY AND MANAGEMENT VANCOMYCIN RESISTANT
ENTEROCOCCI AND CARBAPENEM RESISTANT ENTEROBACTERIACEAE IN
LOW RESOURCE HOSPITAL IN THAILAND
Aree Goonna, Prapaipan wongkrue, Sawalak Fupinwong, Nantana NunNgam,
Chuleewan Yamrubboon. Infection Control Unit, Chiangmai University
Hospital, Chiangmai, Thailand
Background: Hospitals in central part of Thailand has recently emerged Van-
comycin Resistant Enterococci(VRE) and Carbapenem Resistant Enterobac-
teriaceae (CRE) for 3 years ago. These organisms associated with high
mortality and high cost of treatment and care. January 2014 we found the
first case of VRE in Maharaj Nakorn Chiangmai hospital, 1400 bed facility,
a university hospital, we concerned about the spread of the organism and
cost of treatment and care.
Objectives:
1. To study epidemiology of VRE and CRE
2. To implementation infection control and prevention for new emerging
organisms in hospital.
Methods: Prospective surveillance study in all of patients visit our hospital
was done from January to June 2014. The data source for surveillance was
laboratory base system, collected using surveillance methodology and defi-
nition of Center for Disease Control. Data were analysis by using descriptive
statistics.
Implementing infection control strategies concurrent with the surveillance
data. Strategies were; set up the special policy for VRE and CRE , announce
of policy and share the guidelines. Developing manual for health care
personnel, patients and family. Support of some disposable equipment. Set
up a fast tract to notifying laboratory result report and rapid implementa-
tion, strict contact precautions . Environmental control was arranged for
proper strict isolations, in general ward we created isolation chamber with
plastic semi-hard partitions. Active surveillance of close contact patients for
2 weeks and when consequence negative clinical specimens and stool
culture. Strict contact precautions was stopped. Set up one stop service
for out patients.. For referral cases, notification system was performed to
infection control team of other hospitals.
Results: From January to June 2014, we found VRE and CRE of 27 and 25
cases consecutively. The incidence rate of VRE and CRE was 0.198/1000
and 0.184/1000 patient days, Most incident cases found in the medical
department (53.84%). For the VRE incident infected patients were 44.4 % ,
and 54.6 % were colonized patients, HAI were 44.4 % . For CRE infected pa-
tients and colonization were 52.0% and 48.0% . HAI were 40.0 %. About 33%
VRE had received Vancomycin before developed infection and colonization.
For CRE incident 56 % and 36 % had received Cephalosporin, and Carbapenem
before developed CRE. Close contact VRE patient developed colonization
22.2%, and 12.1% for CRE. Compliance of personnel, patients and relatives
were at good level. However, sometimes we encountered shortage of PPE
equipment. The major defect of practice was the thorough cleaning of envi-
ronmental surrounding surface of the patient unit which spot checked by
ATP test.
Conclusion: The incidence of VRE and CRE in Maharaj nakorn chiangmai hos-
pital is similar to incidence of hospitals those of European countries. Patient
close contact VRE index cases developed infection and colonization with VRE
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